| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3189259 | Annales de Dermatologie et de Vénéréologie | 2009 | 7 Pages |
Abstract
Since Arndt-Gottron scleromyxedema is a rare disease, no standardized treatment has been yet established. The combination of minimal adverse effects and real efficacy makes IVIG an interesting alternative treatment for this disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
L. Lopez, E. Wierzbicka-Hainaut, A. Villers, G. Guillet,